A detailed history of American Century Companies Inc transactions in Generation Bio Co. stock. As of the latest transaction made, American Century Companies Inc holds 31,316 shares of GBIO stock, worth $48,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,316
Previous 31,786 1.48%
Holding current value
$48,226
Previous $89,000 13.48%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.16 - $3.51 $1,015 - $1,649
-470 Reduced 1.48%
31,316 $77,000
Q2 2024

Aug 07, 2024

BUY
$2.64 - $4.35 $55,880 - $92,076
21,167 Added 199.33%
31,786 $89,000
Q1 2024

May 14, 2024

BUY
$1.73 - $4.07 $18,370 - $43,219
10,619 New
10,619 $43,000
Q3 2023

Nov 13, 2023

BUY
$3.65 - $6.9 $47,825 - $90,410
13,103 Added 73.67%
30,889 $117,000
Q2 2023

Aug 14, 2023

BUY
$3.5 - $5.67 $25,686 - $41,612
7,339 Added 70.25%
17,786 $97,000
Q1 2023

May 11, 2023

BUY
$3.61 - $7.01 $37,713 - $73,233
10,447 New
10,447 $44,000
Q3 2021

Nov 10, 2021

SELL
$20.0 - $27.43 $4.93 Million - $6.76 Million
-246,377 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$24.34 - $38.34 $2.53 Million - $3.98 Million
103,883 Added 72.9%
246,377 $6.63 Million
Q1 2021

May 14, 2021

BUY
$24.74 - $40.2 $558,431 - $907,394
22,572 Added 18.82%
142,494 $4.06 Million
Q4 2020

Feb 12, 2021

SELL
$21.68 - $51.61 $82,080 - $195,395
-3,786 Reduced 3.06%
119,922 $3.4 Million
Q3 2020

Nov 13, 2020

BUY
$18.07 - $31.84 $27,845 - $49,065
1,541 Added 1.26%
123,708 $3.82 Million
Q2 2020

Aug 13, 2020

BUY
$20.1 - $24.69 $2.46 Million - $3.02 Million
122,167 New
122,167 $2.57 Million

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $90.9M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.